Stage I Grade 3 Follicular Lymphoma Active Not Recruiting Phase 1 / 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0029477 (Stage I Grade 3 Follicular Lymphoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01193842Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell LymphomasTreatment